XOMA 358

· XOMA (US) LLC

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for XOMA 358, covering 2017-02-06 to 2021-05-21. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study of XOMA 358 in Patients With Hypoglycemia After Gastric Bypass Surgery [Phase 2]